...
首页> 外文期刊>Journal of vascular surgery >Emergency stent graft implantation for ruptured visceral artery pseudoaneurysm.
【24h】

Emergency stent graft implantation for ruptured visceral artery pseudoaneurysm.

机译:内脏动脉假性动脉瘤破裂的紧急支架植入术。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Literature series that include visceral artery pseudoaneurysms rarely separate them from true aneurysms, although they address different issues. Guidelines for optimal management of these lesions are lacking. We report our experience of stent graft treatment of these lesions with midterm results. METHODS: We retrospectively reviewed all patients with a visceral pseudoaneurysm who were treated with a stent graft in our institution. Patient history, clinical characteristics, procedure details, and outcome were recorded and analyzed. RESULTS: From March 2004 to June 2009, 10 consecutive patients (9 men), who were a mean age of 59 years, were treated for symptomatic visceral artery pseudoaneurysm, with hemorrhagic shock in 8 patients (80%), after pancreaticoduodenectomy in 8, gastrectomy in 1, and abdominal trauma in 1. A mean of 24 days (range, 7-60 days) passed between the initial surgery or trauma and pseudoaneurysm diagnosis. Septic complications were associated in six patients (60%). The pseudoaneurysm was in the hepatic artery in 8 patients, the splenic artery in 1, and the superior mesenteric artery in 1. Technical and clinical success was achieved in 80% of patients. Two failures of catheterization were followed by redo surgery and death (20%). No patients died postoperatively, and no complications among the patients who were treated successfully. Mean follow-up was 37 months (range, 10-63 months). All stent grafts were patent, with no signs of infection. Two patients died secondary to neoplasm. No rebleeding or recurrent aneurysms were noted. CONCLUSION: Stent graft exclusion of visceral artery pseudoaneurysm seems to be a valid therapeutic approach regardless of the patient's septic or hemodynamic status.
机译:背景:包括内脏动脉假性动脉瘤在内的文献系列尽管将解决不同的问题,但很少将它们与真正的动脉瘤区分开。缺乏最佳管理这些病变的指南。我们报告我们的支架移植治疗这些病变的经验,并获得中期结果。方法:我们回顾性研究了本院所有接受了支架移植的内脏假性动脉瘤患者。记录并分析患者的病史,临床特征,手术细节和结局。结果:从2004年3月至2009年6月,接受胰十二指肠切除术8例,平均年龄59岁的连续10例患者(9名男性)接受了有症状内脏动脉假性动脉瘤的治疗,出血性休克8例(80%)。胃切除术1例,腹部创伤1例。在初次手术或创伤与假性动脉瘤诊断之间平均经过24天(7-60天)。败血症并发症与六名患者(60%)有关。假性动脉瘤在肝动脉中有8例,脾动脉在1例中,肠系膜上动脉在1例中。80%的患者取得了技术和临床成功。两次导管插入失败后,重做手术并死亡(20%)。术后无患者死亡,成功治疗的患者无并发症。平均随访时间为37个月(范围10-63个月)。所有的支架移植物均已获得专利,没有感染迹象。两名患者因肿瘤继发死亡。没有发现再出血或复发性动脉瘤。结论:不管患者的脓毒症或血液动力学状况如何,排除内脏动脉假性动脉瘤的支架移植物似乎是一种有效的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号